U.S. Consumer Durables Stock News

NetApp (NTAP) shares have been relatively steady, showing a minor gain over the past day while posting a slight dip across the last month. Investors seem to be weighing recent performance data as they consider their outlook. See our latest analysis for NetApp. Looking beyond the daily ups and downs, NetApp’s share price has been climbing steadily over the past quarter, reflecting growing investor confidence. However, the total shareholder return over the last year has edged slightly lower...

Ameriprise Financial (AMP) has been quietly navigating shifts in the market over the past month, with the stock edging lower by 1% and underperforming by about 11% over the past 3 months. Investors may be sizing up longer-term value amid recent movements. See our latest analysis for Ameriprise Financial. Ameriprise Financial’s share price has faded a bit lately, and after a period of relative stability, momentum remains soft. The 1-year total shareholder return is -5.87%, despite a standout...

At its 2025 Annual Meeting of Shareholders, Procter & Gamble's Board of Directors declared a quarterly dividend of US$1.0568 per share on both Common and ESOP Convertible Class A Preferred Stock, payable in November to shareholders of record as of October 24, 2025. This 69th consecutive annual dividend increase highlights P&G's consistent financial health and ongoing commitment to returning value to shareholders, even amid questions about relative equity valuations given higher yields in...

DENTSPLY SIRONA (XRAY) has just revealed that a lengthy SEC investigation into its financial reporting has concluded, with no enforcement action being recommended. This clears a lingering regulatory cloud from the company’s outlook. See our latest analysis for DENTSPLY SIRONA. The closure of the SEC investigation helped briefly lift sentiment, but it follows a tough stretch for DENTSPLY SIRONA. Despite promising new leadership hires and operational changes, the company’s 1-year total...

User interest around Semler Scientific (SMLR) has spiked after the company agreed in principle to pay $29.75 million to resolve Department of Justice claims. The settlement comes after multiple class action lawsuits and earlier stock price declines. See our latest analysis for Semler Scientific. The news of Semler Scientific’s DOJ settlement capped a turbulent stretch for the shares, which have lost over 53% in price so far this year and dropped sharply on each new legal headline. Despite...

Wayfair, a leading online home goods retailer, announced that its highly anticipated Way Day shopping event will return from October 26 to 29. The sale is known for deep discounts and free shipping, capturing the attention of both shoppers and investors. See our latest analysis for Wayfair. This year’s anticipation around Way Day comes as Wayfair’s share price has rallied sharply, delivering a 76.5% year-to-date gain and climbing 43.7% over the past three months. While momentum has picked up...

Ingersoll Rand recently reported a strong quarter, surpassing analyst estimates for revenue and adjusted operating income, and raised its full-year guidance for revenue, adjusted EBITDA, and adjusted EPS. Despite beating expectations and improving its outlook, investor concerns about profitability continue to influence market sentiment and test key support and resistance levels for the stock. We'll examine how Ingersoll Rand's improved full-year guidance could impact its long-term investment...

You may think that with a price-to-sales (or "P/S") ratio of 12.6x MediWound Ltd. ( NASDAQ:MDWD ) is a stock to avoid...

Legend Biotech (LEGN) attracted investor attention after the FDA approved a label update for its CARVYKTI therapy, highlighting improved overall survival in a key Phase 3 multiple myeloma study. The update also introduces additional safety warnings, which shape future risk considerations. See our latest analysis for Legend Biotech. Legend Biotech’s recent momentum appears to be building after publicizing $524 million in third-quarter sales for CARVYKTI and securing a favorable regulatory...

If you have been watching CNX Resources, you are definitely not alone. The stock has seen its share of twists and turns, and deciding what to do next can feel like you are at a crossroads. Over the past year, CNX is down 8.3%, and its year-to-date return sits at a disappointing -13.2%. But step back just a little, and the longer-term numbers tell a very different story, with the share price up an impressive 214.4% over the past five years. That kind of growth tends to get noticed, even if the...

Prudential Financial (PRU) has caught investors' attention after a recent decline in its share price. At the same time, the company disclosed preliminary quarterly results highlighting robust cash flow and above-expectation alternative investment income. See our latest analysis for Prudential Financial. Against this backdrop of expansion in key markets like New York and New Jersey, Prudential Financial’s share price has drifted lower in 2025, with a year-to-date decline of 12.8%. Despite...

In October 2025, CACI International announced it had secured a five-year contract worth over US$73 million to continue modernizing the Department of the Air Force’s Integrated Broadcast Services-Network Services, a system supporting secure, multi-domain intelligence and targeting operations for the Department of Defense and allied partners. This award expands CACI's role in developing software-defined, secure military intelligence networks, reinforcing its position as a trusted technology...

M&T Bank Corporation recently reported that net charge-offs reached US$146 million for the third quarter ended September 30, 2025, up from US$108 million in the previous quarter and US$120 million in the same period last year. This increase in loan losses comes just ahead of M&T Bank's scheduled earnings report, drawing investor attention to the bank's credit quality trends. We'll explore how the rise in net charge-offs could influence the outlook for M&T Bank's future earnings and capital...

Donaldson Company (DCI) shares have delivered steady gains over the past few months, climbing 16% in the past 3 months and 22% so far this year. Investors seem to be responding to consistent results and improving financials. See our latest analysis for Donaldson Company. Donaldson’s latest share price gains reflect growing investor optimism, supported by ongoing improvements in its financials and positive annual momentum. With a one-year total shareholder return of 13.5% and an impressive...

Trying to decide what to do with Freeport-McMoRan stock right now? You are definitely not alone. With the price closing recently at $41.71, and a volatile stretch that has seen the share price dip 2.7% over the last week and fall 8.6% in the past month, many investors are reevaluating their positions. But take a step back. Despite these near-term declines, Freeport-McMoRan’s longer-term growth story is hard to ignore, with gains of 53.4% over three years and an impressive 151.5% over...

On September 30, 2025, the White House nominated Jeffrey Kaufmann to the Federal Agricultural Mortgage Corporation’s Board of Directors to replace Chester Culver, whose position ended immediately, pending Senate confirmation. This rapid leadership transition removes an experienced member from key policy and risk committees, raising questions about future board priorities and regulatory engagement. We'll explore how this White House appointment could shape Farmer Mac's governance, policy...

The Hanover Insurance Group recently released its 2025 Homeowners Coverage Awareness Report, highlighting gaps between homeowner insurance awareness and adoption, especially in cyber and umbrella coverage, and also reported strong earnings, a $500 million senior notes offering, and a leadership appointment. The survey found that only 7% of homeowners carry cyber insurance despite nearly half being aware of it, underscoring significant unmet needs and opportunities for education in the...

Deciding what to do with Parker-Hannifin’s stock? You are not alone. In a market full of industrial giants, Parker-Hannifin grabs attention not just for its engineering prowess, but for its impressive share performance. Sure, the past week has seen a dip of 2.1%, and the past month was also slightly in the red at -2.9%, but step back and the bigger picture looks much brighter. Year-to-date, Parker-Hannifin is up 17.2%, nearly matching its one-year gain of 16.9%. The real jaw-dropper is the...

If you’re thinking about what to do with your Comfort Systems USA shares, or maybe whether now is the time to get involved, you’re definitely not alone. This stock has been turning heads lately, and for good reason. After a modest dip of -0.9% in the last week, the share price surged 7.0% over the past month. Zoom out, and those bigger numbers really tell the story: up 95.4% year-to-date, over 100% in the last year, and a staggering 1,463.6% in five years. That kind of consistent...

Zoetis Inc. recently announced that Health Canada has approved Lenivia, a monoclonal antibody therapy offering three months of pain relief from osteoarthritis in dogs with a single injection. This approval marks a significant expansion of Zoetis’ portfolio in the growing market for chronic pain management in companion animals, reflecting the company’s commitment to innovation. In the following section, we’ll explore how Health Canada’s approval of Lenivia may influence Zoetis’ outlook and...

NeoGenomics, Inc. recently presented new clinical data at the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, highlighting the capabilities of its RaDaR ST molecular residual disease (MRD) assay for pharmaceutical partners in oncology research and clinical trials. This development underscores the company's push to enhance precision oncology solutions, leveraging advanced circulating tumor DNA analysis to support real-time, patient-specific monitoring in cancer drug...

Astronics (ATRO) has seen its shares climb nearly 23% over the past month, drawing attention from investors looking for value opportunities in the capital goods sector. With interest in the stock building, many are revisiting its recent performance as well as its long-term prospects. See our latest analysis for Astronics. Momentum has clearly picked up for Astronics, as a 30-day share price return of 22.6% builds on a gain of more than 210% year-to-date. Looking further back, the total...

Thinking about Centrus Energy stock? You are definitely not alone. After all, the past year has seen a staggering rally, with the share price up 463.4% over just the last 12 months. And it is not just a recent fluke. Going back five years, Centrus has delivered a jaw-dropping 4104.4% return for long-term holders. Even in just the last month, the stock surged nearly 80%, catching the attention of both Wall Street pros and regular investors alike. What is driving this momentum? For one, there...

Comerica (CMA) shares have been on the move recently, gaining roughly 14% over the past month and climbing 26% in the past 3 months. Investors seem to be taking a closer look at the bank’s performance. See our latest analysis for Comerica. This latest stretch of momentum follows a year where Comerica’s total shareholder return hit 32%, a clear sign that investors are warming up to the stock. With a recent uptick in the 3-month share price return, interest seems to be building as the market...